Cue Biopharma Inc buy Piper Sandler
Start price
26.07.24
/
50%
€0.61
Target price
26.07.25
€2.76
Performance (%)
20.82%
End price
27.07.25
€0.74
Summary
This prediction ended on 27.07.25 with a price of €0.74. The prediction had a final performance of 20.82%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cue Biopharma Inc | 109.322% | 109.322% | -25.378% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Piper_Sandler for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target lowered by analysts at Piper Sandler from $8.00 to $3.00. They now have an "overweight" rating on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten